Related Experiment Video
Updated: May 20, 2026

07:13
Fluorescent Lateral Flow Immunoassay Based on Quantum Dots Nanobeads
Published on: June 28, 2024
Quantum dot-nucleic acid/aptamer bioconjugate-based fluorimetric biosensors.
1School of Chemistry and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, UK. d.zhou@leeds.ac.uk
Biochemical Society Transactions
|July 24, 2012
Summary
Quantum dot (QD) and nucleic acid (NA) aptamer conjugates offer advanced biosensing for disease diagnosis and environmental monitoring. These QD-NA/aptamer bioconjugate sensors utilize Förster resonance energy transfer (FRET) for sensitive detection.
Area of Science:
- Biotechnology
- Nanotechnology
- Analytical Chemistry
Background:
- Fluorescent semiconductor quantum dots (QDs) conjugated with biomolecules represent a significant advancement in sensing technologies.
- These QD-biomolecule conjugates have shown immense potential across diverse fields including biosensing, environmental monitoring, and disease diagnostics over the past decade.
Purpose of the Study:
- This mini-review focuses on recent progress in biosensors employing quantum dot-nucleic acid (QD-NA) conjugates, with a specific emphasis on NA aptamers.
- The review highlights the application of the Förster resonance energy transfer (FRET) mechanism for target detection in these advanced biosensing platforms.
Main Methods:
- The review discusses strategies for creating compact QD-DNA conjugates.
- It explores various target readout mechanisms employed in QD-aptamer based biosensors.
- Sensing performance metrics and experimental approaches are also detailed.
Main Results:
- Recent developments have led to improved QD-NA/aptamer conjugate designs.
- Effective FRET-based readout strategies have been demonstrated for sensitive detection.
- The performance of these biosensors in various applications has been evaluated.
Conclusions:
- QD-NA/aptamer bioconjugate sensors represent a promising frontier in sensitive and specific detection.
- Further research is needed to address existing challenges and fully realize their potential in diagnostics and monitoring.
- The outlook suggests continued innovation in QD-based biosensing platforms.

